These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14263735)

  • 21. USE OF EPSILON AMINOCAPROIC ACID.
    GANS H
    Surg Gynecol Obstet; 1965 Mar; 120():576-7. PubMed ID: 14262059
    [No Abstract]   [Full Text] [Related]  

  • 22. AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.
    SWEENEY WM
    Am J Med Sci; 1965 May; 249():576-89. PubMed ID: 14283294
    [No Abstract]   [Full Text] [Related]  

  • 23. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 24. ROLE OF INHIBITORS OF FIBRINOLYSIS IN HEPATIC CIRRHOSIS.
    O'CONNELL RA; GROSSI CE; ROUSSELOT LM
    Lancet; 1964 Nov; 2(7367):990-1. PubMed ID: 14201669
    [No Abstract]   [Full Text] [Related]  

  • 25. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 26. [PROTECTIVE ACTIVITY OF SOME ANTIPROTEOLYTIC MOLECULES IN ANAPHYLACTIC TYPE PHENOMENA].
    BERTELLI A; GENOVESE E; LAMI V; ROSSANO MA
    Folia Allergol (Roma); 1965; 12():98-102. PubMed ID: 14319295
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON ALTERATION OF PANCREATIC FUNCTION IN MAN BY PROTEASE INHIBITORS].
    SCHULTIS K; RICK W
    Verh Dtsch Ges Inn Med; 1964; 70():824-8. PubMed ID: 14294315
    [No Abstract]   [Full Text] [Related]  

  • 28. AORTIC ARTERIOSCLEROSIS IN RABBITS. FED INHIBITORS OF FIBRINOLYSIS.
    KWAAN HC; ASTRUP T
    Arch Pathol; 1964 Nov; 78():474-82. PubMed ID: 14200668
    [No Abstract]   [Full Text] [Related]  

  • 29. INHIBITION OF FIBRINOLYTIC ACTIVITY OF PLASMIN BY VARIOUS SYNTHETIC INHIBITORS.
    MURAMATU M; ONISHI T; MAKINO S; FUJII S; YAMAMURA Y
    J Biochem; 1965 Mar; 57():450-3. PubMed ID: 14326102
    [No Abstract]   [Full Text] [Related]  

  • 30. [EXPERIMENT WITH A PLASMIN PREPARATION BY USING THE CASIN SPLITTING TEST: THE ACTION OF PLASMIN-NOVO AND ITS INHIBITION WITH EPSILON-AMINOCAPROIC ACID AND TRASYLOL].
    BERGHOFF A; GLATZEL H
    Thromb Diath Haemorrh; 1964 Dec; 12():418-24. PubMed ID: 14254701
    [No Abstract]   [Full Text] [Related]  

  • 31. EFFECTS OF EPSILON AMINOCAPROIC ACID ON COAGULATION AND FIBRINOLYTIC MECHANISMS.
    LEWIS JH; DOYLE AP
    JAMA; 1964 Apr; 188():56-63. PubMed ID: 14107215
    [No Abstract]   [Full Text] [Related]  

  • 32. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 33. A PERMEABILITY FACTOR RELEASED FROM PHAGOCYTOSING PMN-LEUKOCYTES AND ITS INHIBITION BY PROTEASE INHIBITORS.
    BURKE JS; URIUHARA T; MACMORINE DR; MOVAT HZ
    Life Sci (1962); 1964 Dec; 3():1505-12. PubMed ID: 14248645
    [No Abstract]   [Full Text] [Related]  

  • 34. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M
    Hemostase; 1964 Mar; 4():95-101. PubMed ID: 14188681
    [No Abstract]   [Full Text] [Related]  

  • 35. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM.
    OLOW B
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706
    [No Abstract]   [Full Text] [Related]  

  • 36. INHIBITION OF FIBRINOLYSIS AND FIBRINOGENOLYSIS IN MAN: COMPARISON OF EPILSON-AMINOCAPROIC AID AND KALLIKREIN INHIBITOR.
    BECK E; SCHMUTZLER R; DUCKERT F
    Thromb Diath Haemorrh; 1963 Nov; 10():106-19. PubMed ID: 14081273
    [No Abstract]   [Full Text] [Related]  

  • 37. [FIBRINOLYSIS AND FIBRINOLYTIC SYNDROMES].
    COELI L; DEANGELIS C
    Acta Anaesthesiol; 1964; 15():345-82. PubMed ID: 14196487
    [No Abstract]   [Full Text] [Related]  

  • 38. [PREVENTION AND TREATMENT OF FIBRINOLYTIC HYPERACTIVITY IN UROLOGIC SURGERY].
    CUOCOLO R; DESANTIS S; SPAMPINATO N; GUIDONE M
    Rass Int Clin Ter; 1965 May; 45():468-80. PubMed ID: 14343408
    [No Abstract]   [Full Text] [Related]  

  • 39. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 40. [PRESENT TRENDS IN THE THERAPY OF HYPERFIBRINOLYTIC STATES].
    DETTORI AG; PONARI O
    Clin Ter; 1963 Oct; 27():97-114. PubMed ID: 14100829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.